Efficacy and Safety of Sarilumab in COVID-19: A Systematic Review

Efficacy and Safety of Sarilumab in COVID-19: A Systematic Review

Background. It has been found that there is overactivation of immune response in patients with COVID-19. Several studies are going on to assess the role of immunomodulation. IL-6 antibodies such as tocilizumab have been found to have efficacy in the treatment of COVID-19. We aim to assess the role o...

Full description

Saved in:

Bibliographic Details
Main Authors:	Rajan Chamlagain, Sangam Shah, Basanta Sharma Paudel, Roman Dhital, Bipin Kandel
Format:	Article
Language:	English
Published:	Wiley 2021-01-01
Series:	Interdisciplinary Perspectives on Infectious Diseases
Online Access:	http://dx.doi.org/10.1155/2021/8903435
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Acute Lower Limb Ischemia in COVID-19 Patient with Delayed Presentation
by: Sangam Shah, et al.
Published: (2021-01-01)

Sarilumab is not Inferior to Tocilizumab in the Treatment of Cytokine Release Syndrome in COVID-19
by: V. T. Ivashkin, et al.
Published: (2023-12-01)

Outcomes of tocilizumab and sarilumab for hospitalized patients with COVID-19: retrospective study
by: Ashraf Mokhtar Madkour, et al.
Published: (2025-06-01)

Safety and efficacy of switching from adalimumab to sarilumab in patients with rheumatoid arthritis in the ongoing MONARCH open-label extension
by: Gerd R Burmester, et al.
Published: (2019-10-01)

Efficacy of sarilumab and dexamethasone co-administration for lowering multiple blood biomarkers in the treatment of cytokine release syndrome in hospitalized covid-19 patients
by: Ishtiaq Ahmad, et al.
Published: (2024-06-01)

The efficacy and safety of sarilumab, fully human monoclonal antibodies against interleukin 6 receptor, in rheumatoid arthritis: new evidence
by: E. L. Nasonov, et al.
Published: (2019-11-01)

Efficacy and safety of sarilumab in combination with methotrexate in patients with active rheumatoid arthritis and inadequate effect of methotrexate monotherapy (results of phase III MOBILITY study)
by: E. L. Nasonov, et al.
Published: (2019-05-01)

Efficacy and safety of early treatment with sarilumab in hospitalised adults with COVID-19 presenting cytokine release syndrome (SARICOR STUDY): protocol of a phase II, open-label, randomised, multicentre, controlled clinical trial
by: Jesús Rodríguez-Baño, et al.
Published: (2020-11-01)

Association between tocilizumab, sarilumab and all-cause mortality at 28 days in hospitalised patients with COVID-19: A network meta-analysis.
by: Peter J Godolphin, et al.
Published: (2022-01-01)

Treatment of indolent systemic mastocytosis with sarilumab is not supported in a randomized trial
by: Hirsh D. Komarow, MD, et al.
Published: (2025-08-01)

Case of successful use of sarilumab in secondary renal amyloidosis in a patient with rheumatoid arthritis
by: L. A. Smirnova, et al.
Published: (2022-11-01)

Combination Therapy with Nintedanib and Sarilumab for the Management of Rheumatoid Arthritis Related Interstitial Lung Disease
by: Caterina Vacchi, et al.
Published: (2020-01-01)

Borrelia burgdorferi Infection Is Worth Screening to Investigate Sensorineural Hearing Loss Etiology: A Systematic Review
by: Abhinav Bhattarai, et al.
Published: (2025-07-01)

Efficacy and Safety of Remdesivir for the Treatment of Patients with COVID-19: A Systematic Review
by: Anupa Thampy, et al.
Published: (2025-04-01)

Efficacy and safety of tofacitinib on COVID-19 patients: A systematic review and meta-analysis
by: Gofarana Wilar, et al.
Published: (2024-10-01)

CT-IGFBP-4 as a Predictive Novel Biomarker of Ischemic Cardiovascular Events and Mortality: A Systematic Review
by: Abhinav Bhattarai, et al.
Published: (2022-01-01)

Efficacy and safety of remdesivir and favipiravir in COVID-19 patients – A systematic review and meta-analysis
by: Piyush Vatsha, et al.
Published: (2025-05-01)

Efficacy and safety of arbidol (umifenovir) in patients with COVID‐19: A systematic review and meta‐analysis
by: Behnam Amani, et al.
Published: (2021-12-01)

Efficacy and safety of herbal medicine (Lianhuaqingwen) for treating COVID-19: A systematic review and meta-analysis
by: Ming Liu, et al.
Published: (2021-03-01)

Efficacy and Safety of Acupuncture for Post–COVID-19 Insomnia: Protocol for a Systematic Review and Meta-Analysis
by: Yadi Li, et al.
Published: (2025-03-01)

COVID-19: A brain virus? COVID-19 and neurological manifestations: a systematic review
by: Muhammad Mohsin Khan, et al.
Published: (2025-06-01)

Comparative efficacy and safety of pharmacological interventions for the treatment of COVID-19: A systematic review and network meta-analysis.
by: Min Seo Kim, et al.
Published: (2020-12-01)

Efficacy and safety of traditional Chinese medicine for post-COVID-19 syndrome: a systematic review and meta-analysis
by: Yiting Wang, et al.
Published: (2025-07-01)

Safety, Immunogenicity, and Efficacy of COVID-19 Vaccines in Radiation–Oncology Patients: A Systematic Review and Meta-Analysis
by: Paul Thöne, et al.
Published: (2025-06-01)

The Eﬃcacy and Safety of Riamilovir in the Treatment of Patients with COVID-19
by: А. U. Sabitov, et al.
Published: (2021-05-01)

Efficacy and Safety of Oral Anticoagulants in the Treatment of COVID-19
by: O. G. Ni, et al.
Published: (2021-07-01)

The efficacy and safety of fluvoxamine in patients with COVID-19: A systematic review and meta-analysis from randomized controlled trials.
by: Qiufeng Zhou, et al.
Published: (2024-01-01)

Russian vaccines against COVID-19: their characteristics, efficacy and safety
by: A. E. Bilev, et al.
Published: (2023-01-01)

EFFICACY AND SAFETY OF REGDANVIMAB THERAPY IN MODERATE COURSE OF COVID-19
by: Михаил Исаакович Ликстанов, et al.
Published: (2023-02-01)

Safety and efficacy of COVID-19 vaccines in children and adolescents with cancer
by: Nilgün Kurucu, et al.
Published: (2024-10-01)

The Efficacy and Safety of Monoclonal Antibody Treatments Against COVID-19: A Systematic Review and Meta-analysis of Randomized Clinical Trials
by: Ifan Ali Wafa, et al.
Published: (2023-11-01)

Short-term safety and efficacy of aspirin in patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials
by: Liwen Xue, et al.
Published: (2025-05-01)

Resolution of the National Multidisciplinary Research Council of Experts on the place of anti-interleukin-6 receptor monoclonal antibodies (Sarilumab) in the treatment of patients with rheumatoid arthritis and comorbidity
by: article Editorial
Published: (2020-06-01)

Efficacy of tenofovir on clinical outcomes of COVID-19 patients: a systematic review
by: Thaís Lorenna Souza Sales, et al.
Published: (2025-07-01)

Efficacy and Safety of Tocilizumab Treatment in Tunisian Critically Ill COVID-19 Patients
by: Khadija Bahrini, et al.
Published: (2024-01-01)

Efficacy and safety of azvudine versus nirmatrelvir/ritonavir in cancer patients with COVID-19
by: Bohan Jia, et al.
Published: (2025-03-01)

A meta-analysis of the efficacy and safety of immunomodulators in the treatment of severe COVID-19
by: Xuegui Ju, et al.
Published: (2025-03-01)

Interventions to improve patient safety during the COVID-19 pandemic: a systematic review
by: Elliott R Haut, et al.
Published: (2025-06-01)

Spatiotemporal dynamics and associated drivers of COVID-19 incidence in Nepal
by: Bipin Kumar Acharya, et al.
Published: (2025-08-01)

Efficacy and safety of 3CL protease inhibitors in patients with mild or moderate COVID-19: a systematic review and meta-analysis of randomized controlled trials
by: Nicole Jean Lee, et al.
Published: (2025-08-01)